[1] Centers for Disease Control and Prevention(CDC). Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV related chronic disease. MMWR Recomm Rep, 1998, 47(RR19): 1-39.[2] Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med, 2001, 345(1): 41-52.[3] Williams R. Global challenges in liver disease. Hepatology, 2006, 44(3): 521-526.[4] Chen YD, Liu MY, Yu WL, Li JQ, Peng M, Dai Q, Liu X, Zhou ZQ. Hepatitis C virus infections and genotypes in China. Hepatobiliary Pancreat Dis Int, 2002, 1(2): 194-201.[5] Xia X, Luo J, Bai JL, Yu RB. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health, 2008, 122(10): 990-1003.[6] Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J Virol, 1992, 66(3): 1476-1483.[7] Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy. Science, 1998, 282(5386): 103-107.[8] Kang SM, Choi SH, Park CY, Kim MH, Kim TK, Park JM, Koh MS, Kang HJ, Hwang SB. Monoclonal antibody recognizing N-terminal epitope of hepatitis C virus nonstructural 5B inhibits viral RNA replication. J Viral Hepat, 2008, 15(4): 305-313.[9] 张中林, 山松, 陈曦, 苏宁, 吴祥甫, 钱凯先, 沈桂芳. 丙肝病毒融合抗原基因NS3-C定点整合入衣藻叶绿体基因组的研究. 遗传, 1999, 21(6): 1-173.[10] Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol, 1993, 74(Pt11): 2391-2399.[11] Murphy DG, Willems B, Deschênes M, Hilzenrat N, Mousseau R, Sabbah S. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5′ untranslated region sequences. J Clin Microbiol, 2007, 45(4): 1102-1112.[12] Simmonds P. Genetic diversity and evolution of hepatitis C virus 15-years on. J Gen Virol, 2004, 85(Pt11): 3173-3188.[13] Major ME, Feinstone SM. The molecular virology of hepatitis C. Hepatology, 1997, 25(6): 1527-1538.[14] Pybus OG, Markov PV, Wu A, Tatem AJ. Investigating the endemic transmission of the hepatitis C virus. Int J Parasitol, 2007, 37(8-9): 839-849.[15] Kuiken C, Yusim K, Boykin L, Richardson R. The Los Alamos hepatitis C sequence database. Bioinformatics, 21(3): 379-384.[16] Kryczka W, Brojer E, Zarebska-Michaluk D, Medyńska J, Urbaniak A. Factors influencing natural history of chronic hepatitis C. Med Sci Monit, 2001, (Suppl. 1): 212-216.[17] Nakano I, Fukuda Y, Katano Y, Toyoda H, Hayashi K, Hayakawa T, Kumada T, Nakano S. Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype. Gut, 2001, 49(2): 263-267.[18] Nakano T, Lu L, Liu P, Pybus OG. Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J Infect Dis, 2004, 190(6): 1098-1108.[19] Drummond AJ, Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol, 2007, 7: 214.[20] 敖雁, 朱明星, 徐辰武. 贝叶斯统计在QTL作图中的应用研究进展. 遗传, 2007, 29(6): 668-674.[21] Magiorkinis G, Magiorkinis E, Paraskevis D, Ho SY, Shapiro B, Pybus OG, Allain JP, Hatzakis A. The global spread of hepatitis C virus 1a and 1b: A phylodynamic and phylogeographic analysis. PLoS Med, 2009, 6(12): e1000198.[22] Courtwright D. Dark paradise: a history of opiate addiction in America. Cambridge: Harvard University Press, 2001.[23] Stimson GV. The global diffusion of injecting drug use: implications for human immunodeficiency virus infection. Bull Narc, 1993, 45(1): 3-17.< |